Wells Fargo’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-10
Closed -$1.22K 7622
2023
Q4
$1.22K Buy
+10
New +$765 ﹤0.01% 6182
2016
Q2
Sell
-13
Closed -$7K 6217
2016
Q1
$7K Buy
+13
New +$8.22K ﹤0.01% 5800

Other funds holding LABU

Wells Fargo's LABU Position: Q1 2024 in Review

Wells Fargo sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q1 2024, closing a stake of 10 shares — an estimated $1.22K sold.

Wells Fargo first reported a position in LABU in Q1 2016 and held it in 2 quarters. The position peaked at $7K in Q1 2016. 33 funds tracked by Wall St. Rank hold LABU as of Q1 2024.

  • Wells Fargo reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q1 2024 after selling out during the quarter.
  • Wells Fargo sold 10 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2024, an estimated $1.22K.
  • Wells Fargo first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2016 and held it in 2 quarters.
  • Wells Fargo's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $7K in Q1 2016.
  • 33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2024.

Based on Wells Fargo's 13F filing for Q1 2024, filed 10 May 2024.